Homocysteine and vitamin B 12 concentrations and mortality rates in type 2 diabetes

Objective To assess the role of homocysteine as a risk factor for mortality in diabetic subjects. Methods Homocysteine, vitamin B 12 , and folate concentrations were measured in stored sera of 396 diabetic Pima Indians aged ≥40 years when examined between 1982 and 1985. Vital status was assessed through 2001. Results and Conclusions Over a median follow‐up of 15.7 years, there were 221 deaths—76 were due to cardiovascular disease (CVD), 36 to diabetes/nephropathy and 34 to infections. Homocysteine was positively associated with mortality from all causes (hazard rate ratio (HRR) for highest versus lowest tertile of homocysteine = 1.70, 95% confidence interval (CI) 1.18–2.46), from diabetes/nephropathy (HRR = 2.39, 95% CI 0.94–6.11) and from infectious diseases (HRR = 3.39, 95% CI 1.19–9.70), but not from CVD (HRR = 1.16, 95% CI 0.62–2.17) after adjustment for age, sex and diabetes duration. Homocysteine correlated with serum creatinine ( r = 0.50), and the relationships with mortality rates were not significant after adjustment for creatinine. Vitamin B 12 was positively associated with all‐cause mortality (HRR for 100 pg/mL difference adjusted for age, sex and diabetes duration = 1.15, 95% CI 1.08–1.22) and death from diabetes/nephropathy (HRR = 1.27, 95% CI 1.10–1.46). The association between homocysteine and mortality in type 2 diabetes is not causal, but is confounded by renal disease in Pima Indians. Copyright © 2006 John Wiley & Sons, Ltd.